Metformin Synergistically Potentiates the Antitumor Effects of Imatinib in Colorectal Cancer Cells

키워드

참고문헌 (39)

1. Abdel-Aziz AK, "Modulation of imatinib cytotoxicity by selenite in HCT116 colorectal cancer cells", Basic Clin Pharmaco Toxicol, 116, pp.37~46 (2015)
2. Alimova IN, "Metformin inhibits breast cancer cell growth, colony formation and cell cycle arrest in vitro", Cell Cycle, 8, pp.909~915 (2009)
3. Attoub S, "The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy", Cancer Res, 62, pp.4879~4883 (2002)
4. Ben Sahra I, "The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level", Oncogene, 27, pp.3576~3586 (2008)
5. Chou TC, "Generalized equations for the analysis of inhibitions of Michaelis-Menton and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors", Eur J Biochem, 115, pp.207~216 (1981)
6. Crowley LC, "Pharmacological agents with inherent anti-autophagic activity improve the cytotoxicity of imatinib", Oncol Rep, 29, pp.2261~2268 (2013)
7. De Giorgi U, "Imatinib and gastrointestinal stromal tumors: Where do we go from here?", Mol Cancer Ther, 4, pp.495~501 (2005)
8. Druker BJ, "Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells", Nat Med, 2, pp.561~566 (1996)
9. Evans JM, "Metformin and reduced risk of cancer in diabetic patients", British Medical Journal, 330, pp.1304~1305 (2005)
10. Genander M, "Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression", Cell, 139, pp.769~792 (2009)
11. Hochhaus A, "Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib", Leukemia, 22, pp.1200~1206 (2008)
12. Huguet F, "Growth inhibition by STI571 in combination with radiation in human chronic myelogenous leukemia K562 cells", Mol Cancer Ther, 7, pp.398~406 (2008)
13. Isakovic A, "Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis", Cell Mol Life Sci, 64, pp.1290~1302 (2007)
14. Joensuu H, "Effect of the tyrosine kinase inhibitor ST1571 in a patient with metastatic gastrointestinal stromal tumor", N Engl J Med, 344, pp.1052~1056 (2001)
15. Kundu P, "An EphB-Abl signaling pathway is associated with intestinal tumor initiation and growth", Sci Transl Med, 7(281), pp.281~244 (2015)
16. Lee JH, "The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus", Int J Cancer, 131, pp.752~759 (2011)
17. Li H, "Inhibition of autophagy enhances apoptosis induced by the PI3K", AKT, Cell Biochem Funct, pp.2013, 31[DOI]
18. Mendoza MC, "The RAS-ERK and PI3K-mTOR pathways: cross-talk and compensation", Trends Biochem Sci, 36, pp.320~327 (2011)
19. Mizushima N, "Methods in mammalian autophagy research", Cell, 140, pp.313~326 (2010)
20. Nanglia-Makker P, "Metformin: a potential therapeutic agent for recurrent colon cancer", PLoS One, 9(1), pp.e84369~ (2014)
21. Niehr F, "Combination therapy with vemurafenib (PLX4032", RG7204) and metformin in melanoma cell lines with distinct driver mutations, 2011, pp.9, 76~88
22. Norbury C, "Animal cell cycles and their control", Trends Biochem Sci, 19, pp.143~145 (1992)
23. O’Hare T, "Targeting the BCR-ABL signaling pathway in therapy resistant Philadelphia chromosome-positive leukemia", Clin Cancer Res, 17, pp.212~221 (2011)
24. 박덕배, "Biphasic Activity of Chloroquine in Human Colorectal Cancer Cells", 발생과 생식, 18(4), pp.225~231 (2014), 한국발생생물학회
25. Popow-Wozniak A, "Apoptotic effect of imatinib on human colon adenocarcinoma cells: Influence on actin cytoskeleton organization and cell migration", Eur J Pharmacol, 667, pp.66~73 (2011)
26. Quinn BJ, "Repositioning metformin for cancer prevention and treatment", Trends Endocrinol Metab, 24(9), pp.469~480 (2013)
27. Saglio G, "Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia", N Engl J Med, 362, pp.2251~2259 (2010)
28. Shaw RJ, "The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin", Science, 310, pp.1642~1646 (2005)
29. Shi R, "The antileukemia effect of metformin in the Philadelphia chromosome-positive leukemia cell line and patient primary leukemia cell", Anti-Cancer Drugs, 26(9), pp.913~922 (2015)
30. Ji-Hoon Song, "Mechanism of Ethanol-induced Purkinje Cell Death in Developing Rat Cerebellum: Its Implication in Apoptosis and Oxidative Damage", 발생과 생식, 15(3), pp.205~213 (2011), 한국발생생물학회
31. Stahtea XN, "Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-MMP2 activation", Int J Cancer, 121, pp.2808~2814 (2007)
32. Sui X, "Autophagy and chemotherapy resistance: A promising therapeutic target for cancer treatment", Cell Death Dis, 4, pp.e838~ (2013)
33. Takeuchi H, "Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase", protein kinase B inhibitors, 2005, pp.65, 3336~3346
34. Tomimoto A, "Metformin suppresses intestinal polyp growth in ApcMin", + mice, 2008, pp.99, 2136~2141
35. Wheaton WW, "Metfromin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis", eLife, 3, pp.e02242~ (2014)
36. Wilcock C, "Accumulation of metformin by tissues of the normal and diabetic mouse", Xenobiotica, 24, pp.49~57 (1994)
37. Yang ZJ, "The role of autophagy in cancer: Therapeutic implications", Mol Cancer Ther, 10, pp.1533~1541 (2011)
38. Zhang J, "Targeting cancer with small molecule kinase inhibitors", Nature Rev Cancer, 9, pp.28~39 (2009)
39. Zhang Y, "Effects of metformin on CD133+ colorectal cancer cells in diabetic patients", PLoS One, 8(11), pp.e81264~ (2013)

관련 논문AI추천